Joanna Kelly

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

Sobha Sivaprasad, A Toby Prevost, Joana C. Vasconcelos et al. · The Lancet · 2017 · 387 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial

Andrew P. Cope, Marianna Jasenecova, Joana C. Vasconcelos et al. · The Lancet · 2024 · 160 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Randomized controlled double‐blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability

Emily Simonoff, Eric Taylor, Gillian Baird et al. · Journal of Child Psychology and Psychiatry · 2012 · 114 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

Philip Hykin, A Toby Prevost, Joana C. Vasconcelos et al. · JAMA Ophthalmology · 2019 · 111 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

Mariam Al-Laith, Marianna Jasenecova, Sonya Abraham et al. · Trials · 2019 · 100 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16